The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment outcomes for patients (Pts) with metastatic castration resistant prostate cancer (mCRPC) pts and DNA damage repair gene mutations.
 
Steven Yip
No Relationships to Disclose
 
Arkhjamil Angeles
No Relationships to Disclose
 
Arshia Beigi
No Relationships to Disclose
 
Evan W Warner
No Relationships to Disclose
 
Daniel Khalaf
No Relationships to Disclose
 
Katherine Sunderland
No Relationships to Disclose
 
Gillian Rae Vandekerkhove
No Relationships to Disclose
 
Matti Annala
No Relationships to Disclose
 
Kasmintan A Schrader
No Relationships to Disclose
 
Alexander William Wyatt
Consulting or Advisory Role - Genzyme
Speakers' Bureau - Janssen
 
Kim N. Chi
Honoraria - Amgen; Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Lilly/ImClone (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst)